Phase XIV, group 2 - 01.09.2021 - 30.08.2024

Ca.-No 200

The role of Tet2/3-mediated DANN demethylation in intestinal tumor formation

Israeli Partner: Yehuditkri Bergman, Hebrew University
German Partner: Frank Lyko, DKFZ

Ca.-No 201

DαRT and PSMA-TαT combination therapy for prostate cancer as a precision medicine approach

Israeli Partner: Tomer Cooks, Ben-Gurion University
German Partner: Martina Benesova, DKFZ

Ca.-No 202

Combating glioblastoma: An exosome nanosystem to bypass biological barriers for effective brain delivery of a tumor-specific peptide therapy

Israeli Partner: Rachela Popvtzer, Bar Ilan University
German Partner: Violaine Goidts, DKFZ

Ca.-No 203

The role of replication stress in chromothripsis, a unique form of genomic instability

Israeli Partner: Batsheva Kerem, Hebrew University
German Partner: Aurelie Ernst, DKFZ

Publications

No publications available.

Ca.-No 204

Impact of sex-related differences on susceptibility, prognosis and therapy of head and neck squamous cell carcinoma

Israeli Partner: Moshe Elkabets, Ben-Gurion University
German Partner: Ina Kurth, Jochen Hess, DKFZ

Publications

Ca.-No 205

Pancreas and liver metaplasia – causes and consequences

Israeli Partner: Eli Pikarsky, Hebrew University
German Partner: Ana Martin-Villalba, DKFZ

Publications

No publications available.

Formular

Formulardaten werden geladen ...